Lv1
80 积分 2023-12-01 加入
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
9天前
已完结
Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics
25天前
已完结
Massive-scale parallel gene synthesis with oligonucleotide hybridization
30天前
已完结
The rise of bispecific antibodies for dual targeting, singular impact: technology and clinical advancements
1个月前
已完结
Generation of PT101, a highly selective IL-2 mutein for treatment of autoimmune diseases
1个月前
已完结
Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides
1个月前
已完结
A cancer vaccine based on N-linked sialyl-Tn antigen elicits robust and selective antitumor immunity
2个月前
已完结
First-in-human study on tolerability, pharmacokinetics and pharmacodynamics of single and multiple escalating doses of XKH001, a recombinant humanized monoclonal antibody against IL-25 in healthy Chinese volunteers
3个月前
已完结
Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides
3个月前
已完结
A guide to complement biology, pathology and therapeutic opportunity
4个月前
已完结
皖公网安备34019202002308
